Biohaven Pharmaceutical Holding Company Ltd.
Equities
BHVN
VGG111961055
Biotechnology & Medical Research
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
38.54 USD | -0.48% | +3.97% | -74.51% |
05-15 | Biohaven Insider Bought Shares Worth $512,877, According to a Recent SEC Filing | MT |
05-14 | Biohaven Insider Bought Shares Worth $1,002,470, According to a Recent SEC Filing | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
-74.51% | 541M | |
+53.67% | 55.07B | |
-1.59% | 41.79B | |
+45.09% | 40.22B | |
-7.59% | 28.17B | |
+12.52% | 26.28B | |
-20.56% | 18.93B | |
+7.45% | 13.03B | |
+28.90% | 12.26B | |
+26.29% | 12.21B |
- Stock Market
- Equities
- BHVN Stock
- News Biohaven Pharmaceutical Holding Company Ltd.
- Piper Sandler Downgrades Biohaven Pharmaceutical to Neutral From Overweight, Maintains $149 Price Target